Wednesday, July 8, 2026

pharma · Idiopathic Pulmonary Fibrosis · Prevention of breast cancer in women with a BRCA1 germline mutation

Shanghai Zerun Biotechnology

News and analysis for Shanghai Zerun Biotechnology on NovaPharmaNews — regulatory, clinical, and market coverage.

936号 Zhangheng Rd, Shanghai 201203, CN HQ
21 Employees
NMPA registrant Type
Company details
Status
Public
HQ
936号 Zhangheng Rd, Shanghai 201203, CN
Employees
21
Programs
11
Drugs
33
Patents
11
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Shanghai Zerun Biotechnology — regulatory, clinical, and market coverage.

News and analysis for Shanghai Zerun Biotechnology on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Shanghai Zerun Biotechnology yet.

Back to company overview →